MedTrace Logo

Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors

NCT02526511 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2023-04-11

No results posted yet for this study

Summary

This pilot clinical trial studies perfusion magnetic resonance imaging in diagnosing patients with kidney tumors. Diagnostic procedures, such as perfusion magnetic resonance imaging, may help find and diagnose kidney tumors and predict and monitor a patient's response to treatment.

Conditions

  • Stage I Renal Cell Cancer
  • Stage II Renal Cell Cancer
  • Stage III Renal Cell Cancer
  • Stage IV Renal Cell Cancer

Interventions

PROCEDURE

Arterial Spin Labeling Magnetic Resonance Imaging

Undergo arterial spin labeled perfusion magnetic resonance imaging

PROCEDURE

Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Undergo dynamic contrast-enhanced perfusion magnetic resonance imaging

PROCEDURE

Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging

Undergo dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging

PROCEDURE

Perfusion Magnetic Resonance Imaging

Undergo perfusion magnetic resonance imaging

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Rutgers Cancer Institute of New Jersey

    collaborator OTHER

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • David Foran · Rutgers Cancer Institute of New Jersey

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-15
Primary Completion
2025-07-28
Completion
2025-09-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02526511 on ClinicalTrials.gov